CA2502489C - Systemes et procedes de distribution de produits medicaux - Google Patents
Systemes et procedes de distribution de produits medicaux Download PDFInfo
- Publication number
- CA2502489C CA2502489C CA2502489A CA2502489A CA2502489C CA 2502489 C CA2502489 C CA 2502489C CA 2502489 A CA2502489 A CA 2502489A CA 2502489 A CA2502489 A CA 2502489A CA 2502489 C CA2502489 C CA 2502489C
- Authority
- CA
- Canada
- Prior art keywords
- user
- dispensing
- drug
- dispense
- label
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 246
- 229940127554 medical product Drugs 0.000 title abstract description 124
- 239000003814 drug Substances 0.000 claims abstract description 463
- 238000003860 storage Methods 0.000 claims description 31
- 238000012545 processing Methods 0.000 claims description 17
- 238000007639 printing Methods 0.000 claims description 14
- 230000004044 response Effects 0.000 claims description 13
- 239000003550 marker Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 abstract description 422
- 238000004891 communication Methods 0.000 abstract description 53
- 238000002483 medication Methods 0.000 abstract description 41
- 238000012384 transportation and delivery Methods 0.000 abstract description 7
- 230000008569 process Effects 0.000 description 105
- 238000012423 maintenance Methods 0.000 description 35
- 238000013515 script Methods 0.000 description 34
- 238000012546 transfer Methods 0.000 description 29
- 230000006870 function Effects 0.000 description 28
- 239000000955 prescription drug Substances 0.000 description 25
- 238000012552 review Methods 0.000 description 25
- 238000010586 diagram Methods 0.000 description 22
- 238000002372 labelling Methods 0.000 description 18
- 239000000820 nonprescription drug Substances 0.000 description 18
- 230000008901 benefit Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 238000007726 management method Methods 0.000 description 14
- 239000007858 starting material Substances 0.000 description 14
- 230000001276 controlling effect Effects 0.000 description 13
- 230000000007 visual effect Effects 0.000 description 13
- 238000009826 distribution Methods 0.000 description 12
- 238000005070 sampling Methods 0.000 description 12
- 230000007613 environmental effect Effects 0.000 description 11
- 230000007246 mechanism Effects 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 230000033228 biological regulation Effects 0.000 description 9
- 238000012795 verification Methods 0.000 description 9
- 238000013475 authorization Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 6
- 238000012806 monitoring device Methods 0.000 description 6
- 239000004065 semiconductor Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 239000003990 capacitor Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- 239000012080 ambient air Substances 0.000 description 4
- 239000007894 caplet Substances 0.000 description 4
- 239000000599 controlled substance Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003811 finger Anatomy 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 239000004081 narcotic agent Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229940124641 pain reliever Drugs 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000003507 refrigerant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000003442 weekly effect Effects 0.000 description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000003570 air Substances 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 229940126534 drug product Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003168 generic drug Substances 0.000 description 3
- 210000004247 hand Anatomy 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000006855 networking Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 206010013700 Drug hypersensitivity Diseases 0.000 description 2
- 206010013710 Drug interaction Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000005311 drug allergy Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- -1 for example Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- HRANPRDGABOKNQ-ORGXEYTDSA-N (1r,3r,3as,3br,7ar,8as,8bs,8cs,10as)-1-acetyl-5-chloro-3-hydroxy-8b,10a-dimethyl-7-oxo-1,2,3,3a,3b,7,7a,8,8a,8b,8c,9,10,10a-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-1-yl acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1[C@H](O)C[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 HRANPRDGABOKNQ-ORGXEYTDSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 208000036647 Medication errors Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 241001441724 Tetraodontidae Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940126606 authorized medical product Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000012769 display material Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000013439 planning Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
L'invention concerne des systèmes et des procédés de distribution à distance de produits médicaux emballés ou non par l'intermédiaire d'un système de communications en réseau. Dans un mode de réalisation préféré de l'invention, on utilise un réseau pour la distribution sûre d'informations confidentielles relatives à un patient et l'envoi d'instructions de distribution à une station de distribution distante. Dans un autre mode de réalisation préféré, l'invention concerne des systèmes et des procédés de distribution d'échantillons de médicaments ou d'autres produits médicaux. Dans un dernier mode de réalisation préféré, l'invention concerne un système et un procédé de distribution de médicaments vendus sans ordonnance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2833710A CA2833710C (fr) | 2002-10-16 | 2003-10-16 | Systemes et procedes de distribution de produits medicaux |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/272,516 | 2002-10-16 | ||
| US10/272,516 US7006893B2 (en) | 1999-09-22 | 2002-10-16 | Systems for dispensing medical products |
| PCT/US2003/032668 WO2004036479A2 (fr) | 1999-12-03 | 2003-10-16 | Systemes et procedes de distribution de produits medicaux |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2833710A Division CA2833710C (fr) | 2002-10-16 | 2003-10-16 | Systemes et procedes de distribution de produits medicaux |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2502489A1 CA2502489A1 (fr) | 2004-04-29 |
| CA2502489C true CA2502489C (fr) | 2014-02-04 |
Family
ID=34312007
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2833710A Expired - Lifetime CA2833710C (fr) | 2002-10-16 | 2003-10-16 | Systemes et procedes de distribution de produits medicaux |
| CA2502489A Expired - Lifetime CA2502489C (fr) | 2002-10-16 | 2003-10-16 | Systemes et procedes de distribution de produits medicaux |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2833710A Expired - Lifetime CA2833710C (fr) | 2002-10-16 | 2003-10-16 | Systemes et procedes de distribution de produits medicaux |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003287096A1 (fr) |
| CA (2) | CA2833710C (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11518615B2 (en) * | 2019-05-29 | 2022-12-06 | Ethicon, Inc. | Inventory system and methods of using the same |
| US11724881B2 (en) | 2019-05-29 | 2023-08-15 | Ethicon, Inc. | Distribution and inventory system and methods of using the same |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10424408B2 (en) | 2018-01-05 | 2019-09-24 | Express Scripts Strategic Development, Inc. | Pharmacy order processing system |
-
2003
- 2003-10-16 AU AU2003287096A patent/AU2003287096A1/en not_active Abandoned
- 2003-10-16 CA CA2833710A patent/CA2833710C/fr not_active Expired - Lifetime
- 2003-10-16 CA CA2502489A patent/CA2502489C/fr not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11518615B2 (en) * | 2019-05-29 | 2022-12-06 | Ethicon, Inc. | Inventory system and methods of using the same |
| US11724881B2 (en) | 2019-05-29 | 2023-08-15 | Ethicon, Inc. | Distribution and inventory system and methods of using the same |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2833710A1 (fr) | 2004-04-29 |
| CA2502489A1 (fr) | 2004-04-29 |
| CA2833710C (fr) | 2017-11-14 |
| AU2003287096A1 (en) | 2004-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7006893B2 (en) | Systems for dispensing medical products | |
| US6735497B2 (en) | Systems and methods for dispensing medical products | |
| US6814254B2 (en) | Method for controlling a drug dispensing system | |
| CA2502489C (fr) | Systemes et procedes de distribution de produits medicaux |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20231016 |